In this study, it has been confirmed that Let-7a is a crucial regulator of the sensitivity of melanoma cells to combined therapy-induced apoptosis by targeting caspase-3, which is considered the primary executor of caspase of apoptosis. This evidence concerns the gene CASP3 and melanoma.